Updated: January 28, 2026
How to Help Your Patients Save Money on Adefovir: A Provider's Guide to Savings Programs
Author
Peter Daggett
ChatGPT
Claude
Gemini
Overview
A guide for providers on how to help hepatitis B patients reduce adefovir costs through patient assistance programs, insurance optimization, and discount resources.
Is Adefovir in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Adefovir near you.
Adefovir dipivoxil is a generic medication, but "generic" does not always mean affordable. Without insurance or a discount card, the retail cash price for a 30-day supply can exceed $1,260. For patients on long-term hepatitis B therapy, cost barriers can lead to non-adherence — and non-adherence in hepatitis B can have serious hepatic consequences. This guide gives providers practical tools to help patients access adefovir at sustainable cost.
Understanding Adefovir Pricing in 2026
The cost landscape for adefovir in 2026:
Retail cash price (uninsured): $520–$1,260 per 30-day supply of generic adefovir dipivoxil 10 mg
With GoodRx/SingleCare discount: Approximately $520–$630 at participating pharmacies
Medicare Part D copay: $10–$75 depending on plan and tier (generic covered; brand Hepsera is NOT covered by Medicare)
Commercial insurance copay: $10–$75 (Tier 2-3 on most plans); prior authorization may be required
Check live stock now.
Patient Assistance Programs (PAPs) for Adefovir
Gilead Advancing Access (for brand Hepsera): Gilead Sciences offers patient assistance through the Advancing Access program for eligible uninsured or underinsured patients who cannot afford Hepsera. Eligibility is income-based. Providers can help patients enroll at gileadadvancingaccess.com or call 1-800-226-2056. Note: this program is for brand Hepsera specifically, not generic adefovir dipivoxil.
NeedyMeds.org: Maintains a comprehensive, searchable database of manufacturer PAPs and disease-specific assistance funds. Search for adefovir or chronic hepatitis B to find relevant programs. This is a useful resource to share with patients or have available in your office.
Hepatitis B Foundation: The Hepatitis B Foundation (hepb.org) maintains resources for patients needing financial assistance with hepatitis B medications. Refer patients to their website for up-to-date support resources.
Prescription Discount Cards: What to Recommend to Patients
For patients who are uninsured or whose insurance does not cover generic adefovir, discount cards provide immediate savings:
GoodRx: Most widely accepted. Patients can compare prices at nearby pharmacies at goodrx.com before filling. Accepted at CVS, Walgreens, Walmart, Kroger, and thousands of independent pharmacies.
SingleCare: Consistently competitive pricing for adefovir dipivoxil. Prices of approximately $626 for 30-day supply at participating pharmacies.
Mark Cuban Cost Plus Drugs: For self-pay patients, costplusdrugs.com offers significantly lower pricing on adefovir. Ships to most states. No insurance needed.
Key clinical note: Patients cannot use discount cards and insurance simultaneously. Advise them to calculate whether their insurance copay or the discount card price is lower before filling.
Insurance Optimization Strategies
Prior authorization (PA) support: Some commercial plans require PA for adefovir at Tier 3. Document the clinical rationale clearly: lamivudine-resistant HBV, contraindication to first-line agents, or established stability on current regimen. A brief letter from the prescriber is usually sufficient.
Medicare Part D — confirm generic coverage: Generic adefovir dipivoxil is covered by Medicare Part D; brand Hepsera is not. If your patient is on Medicare and having cost issues with Hepsera, switching to generic (which is therapeutically equivalent) eliminates coverage complications. Ensure the prescription specifically states "generic acceptable."
90-day mail-order fills: Many insurance plans offer reduced copays for 90-day mail-order supplies compared to monthly retail fills. Recommend this option for all stable patients — it also resolves monthly availability struggles.
Extra Help (Medicare Low Income Subsidy): For Medicare patients with limited income and resources, Extra Help (also called LIS) can dramatically reduce Part D copays. Ask your social work team or care coordinator to screen eligible patients.
Is Switching to a Cheaper Alternative Appropriate?
If cost is a primary driver of non-adherence, consider whether transitioning to a first-line agent might resolve both the cost and availability problems simultaneously. Entecavir (generic) and tenofovir DF (generic) are both:
More widely stocked at retail pharmacies
More potent than adefovir
Potentially less expensive in some settings due to higher volume pricing
Always evaluate resistance history, renal function, and prior treatment before switching. Do not overlap adefovir with tenofovir.
Helping Patients Who Cannot Find Adefovir
For patients who cannot locate adefovir at local pharmacies, medfinder for providers calls pharmacies near the patient to identify which ones can fill the prescription today — without burdening your staff. See the full provider guide: How to Help Your Patients Find Adefovir in Stock
Frequently Asked Questions
For brand-name Hepsera, the Gilead Advancing Access program provides free or reduced-cost medication to eligible uninsured or underinsured patients (call 1-800-226-2056 or visit gileadadvancingaccess.com). For generic adefovir dipivoxil, discount programs like GoodRx, SingleCare, and Mark Cuban's Cost Plus Drugs are the most accessible savings tools for out-of-pocket patients.
Yes — Medicare Part D covers generic adefovir dipivoxil, typically at Tier 2 or Tier 3 with a copay of $10–$75 depending on the plan. Brand-name Hepsera is NOT covered by Medicare. Patients on Medicare who are being prescribed Hepsera should be switched to generic, which is therapeutically equivalent and covered. Patients with low income may qualify for Extra Help (LIS) to reduce copays further.
Document the clinical indication clearly in your PA letter: active chronic hepatitis B with evidence of viral replication, prior treatment history (especially lamivudine resistance if applicable), and why adefovir is the appropriate choice versus first-line agents. Include current HBV DNA levels, liver function tests, and renal function. Most plans accept PA requests through their provider portal or by fax.
This can be a reasonable solution if the patient has no contraindications and their resistance history allows it. Generic entecavir and tenofovir DF are both more widely available and potentially more affordable than adefovir. Evaluate resistance mutations, renal function, and prior therapy carefully before switching. Do not overlap adefovir and tenofovir. Monitor liver enzymes and HBV DNA post-switch.
Staff can help by recommending medfinder.com to locate pharmacies with adefovir in stock, printing a GoodRx coupon from the patient's chart, identifying mail-order pharmacy options through the patient's insurance, and screening for eligibility in the Gilead Advancing Access program or Medicare Extra Help. Including a brief note about these resources in your after-visit summary can significantly reduce access barriers for your patients.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Adefovir also looked for:
More about Adefovir
Why Is Adefovir So Hard to Find? [Explained for 2026]
How to Find Adefovir in Stock Near You (Tools + Tips)
Alternatives to Adefovir If You Can't Fill Your Prescription
Adefovir Shortage Update: What Patients Need to Know in 2026
Adefovir Shortage: What Providers and Prescribers Need to Know in 2026
How to Help Your Patients Find Adefovir in Stock: A Provider's Guide
39,333 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.